All In MedTech

Device Trial Radar · NCT02927327

Clinical Evaluation Of MP26 Features in Adults

Last checked: Nov 20, 2026Latest source record: Dec 6, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

61

Actual

Start

Nov 2016

Primary completion

Sep 20, 2017

Study completion Sep 20, 2017

Sponsor

Lead sponsor
GE HealthcarePublic (GEHC)
Sponsor type
Industry
First posted
Oct 7, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Other
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to collect representative clinical images (head and whole-body scans) of demonstrated diagnostic quality using the next-generation SIGNA PET/MR device equipped with investigational software components in adult population. The images and summary data from this study are intended for use in regulatory submission.

Conditions

  • Brain Imaging
  • Whole Body Imaging

Interventions

  • Zero Echo Time (ZTE) scan for head attenuationDevice

    The GE SIGNA PET/MR MP26 software platform includes the zero echo time (ZTE) scan for head attenuation and Q.Static. The ZTE MR software feature has the potential to enable better visualization of bones, including those in the head, by employing optimal head attenuation correction in PET/MR. PET/MR ZTE MRAC

  • Q.Static (Q. MRAC) for respiratory motion correctionDevice

    An improved Q.Static feature with Q. MRAC, where phase matching the MRAC with the quiescent phase is employed to get more accurate attenuation correction for our Q.Static PET images. PET/MR Q Static (Q. MRAC)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Diagnostic Image QualityTime frame: through study completion, an average of 2 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic

    Rochester, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.